Return to homepagePandemic Pact

Drug repurposing against key COVID-19 Drug Targets using advance Machine Learning based algorithms

Grant number: CVD/2020/000447

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    SERB India

  • Principal Investigator

    Dr. Manoj Kumar Yadav

  • Research Location

    India

  • Lead Research Institution

    SRM University

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Drug repurposing against key COVID-19 targets

Publicationslinked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an in-silico study.

Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2.